COLCORONA Trial

Category

Big Money, Politics & Fed Gov Redirects & Captivates Mass Attention: Obscuring Pragmatic Off-Label Studies Targeting COVID-19

COVID-19 therapeutic clinical trials involving off-label, generics and those sponsored by small biotech generally continue to experience delays due to lack of awareness during the political season, consolidation of federal research power during the pandemic as well as...

At-Home Decentralized COLCORONA Trial Investigates if Colchicine Keeps COVID-19 Symptoms from Progressing to Reduce Hospitalization & Death

There is presently no available, FDA-approved medicine that can be administered at a patient’s home that can prevent the negative progression of SARS-CoV-2 symptoms leading to hospitalization and potentially death. Can a widely available, generic drug used for gout...